TSPAN17
Tetraspanin-17
Also known as: FBX23, FBXO23, TM4SF17, TSN17_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96FV3
- Gene
- TSPAN17
- Ensembl
- ENSG00000048140
- Chromosome
- 5
- Canonical length
- 270 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the transmembrane 4 superfamily. It is characterized by four tetraspanin transmembrane segments. The function of this gene has not yet been determined. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
270 residues, UniProt reviewed canonical sequence.
>Q96FV3|TSPAN17
1 MPGKHQHFQE PEVGCCGKYF LFGFNIVFWV LGALFLAIGL WAWGEKGVLS NISALTDLGG
61 LDPVWLFVVV GGVMSVLGFA GCIGALRENT FLLKFFSVFL GLIFFLELAT GILAFVFKDW
121 IRDQLNLFIN NNVKAYRDDI DLQNLIDFAQ EYWSCCGARG PNDWNLNIYF NCTDLNPSRE
181 RCGVPFSCCV RDPAEDVLNT QCGYDVRLKL ELEQQGFIHT KGCVGQFEKW LQDNLIVVAG
241 VFMGIALLQI FGICLAQNLV SDIKAVKANWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSPAN17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 55 nTPM
- skeletal muscle: 39 nTPM
- adrenal gland: 38 nTPM
- heart muscle: 27 nTPM
- cerebral cortex: 25 nTPM
- pancreas: 25 nTPM
Single-cell type
- erythrocyte progenitors: 73 nCPM
- esophageal apical cells: 44 nCPM
- esophageal suprabasal cells: 40 nCPM
- esophageal basal cells: 32 nCPM
- foveolar cells: 28 nCPM
- enterocytes: 27 nCPM
Immune cell
- T-reg: 7.5 nTPM
- memory CD8 T-cell: 6.2 nTPM
- non-classical monocyte: 3.9 nTPM
- gdT-cell: 3.8 nTPM
- MAIT T-cell: 3.1 nTPM
- NK-cell: 3 nTPM
Brain region
- cerebral cortex: 30 nTPM
- basal ganglia: 26 nTPM
- amygdala: 23 nTPM
- hippocampal formation: 23 nTPM
- thalamus: 20 nTPM
- choroid plexus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- establishment of protein localization to organelle
- intracellular protein localization
- regulation of membrane protein ectodomain proteolysis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSPAN17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSPAN17 as an antibody target. Whether an autoantibody or antibody against TSPAN17 could matter depends on whether native TSPAN17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSPAN17 is annotated at the cell surface, where native TSPAN17 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TSPAN17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...